Example collocations logo

Developing in sentence

6154 examples of Developing in a sentence

And third, the engagement in developing countries was with a narrow set of government elites with little interaction with the citizens, who are the ultimate beneficiaries of development assistance.
You know, developing countries today will not simply accept solutions that are handed down to them by the U.S., Europe or the World Bank.
But in the developing world, things are quite different.
I started looking at wheelchairs in developing countries in 2005, when I spent the summer assessing the state of technology in Tanzania, and I talked to wheelchair users, wheelchair manufacturers, disability groups, and what stood out to me is that there wasn't a device available that was designed for rural areas, that could go fast and efficiently on many types of terrain.
But these are two products available in the U.S. that would be difficult to transfer into developing countries because they're much, much too expensive.
The first is that this product works well because we were effectively able to combine rigorous engineering science and analysis with user-centered design focused on the social and usage and economic factors important to wheelchair users in the developing countries.
And these are all merits that are not just good in the developing world.
And this is a schematic of a bioreactor we're developing in our lab to help engineer tissues in a more modular, scalable way.
Essentially, we're dramatically speeding up that feedback between developing a molecule and learning about how it acts in the human body.
There were countries that did not recognize pharmaceutical product patents, such as India, and Indian pharmaceutical companies started to produce so-called generic versions, low-cost copies of antiretroviral medicines, and make them available in the developing world, and within a year the price had come down from 10,000 dollars per patient per year to 350 dollars per patient per year, and today that same triple pill cocktail is available for 60 dollars per patient per year, and of course that started to have an enormous effect on the number of people who could afford access to those medicines.
This is what you see today, and this is in developing countries, so what that means is, unless we do something deliberate and unless we do something now, we will very soon be faced with another drug price crisis, because new drugs are developed, new drugs go to market, but these medicines are patented in a much wider range of countries.
The rule is about a 10-year delay for a new product to go to market in developing countries, if at all.
I do not stand here today to suggest in any way that conducting HIV clinical trials in developing countries is bad.
On the contrary, clinical trials are extremely useful tools, and are much needed to address the burden of disease in developing countries.
However, the inequalities that exist between richer countries and developing countries in terms of funding pose a real risk for exploitation, especially in the context of externally-funded research.
Sadly enough, the fact remains that a lot of the studies that are conducted in developing countries could never be authorized in the richer countries which fund the research.
I'm sure you must be asking yourselves what makes developing countries, especially those in sub-Saharan Africa, so attractive for these HIV clinical trials?
As funding for HIV research increases in developing countries and ethical review in richer countries become more strict, you can see why this context becomes very, very attractive.
This is especially important in developing countries, where a lot of participants consent to research because they believe it is the only way in which they can receive medical care or other benefits.
Consent procedures that are used in richer countries are often inappropriate or ineffective in a lot of developing countries.
However, the best current treatment available anywhere in the world is often very difficult to provide in developing countries.
Unfortunately, this is often lacking or inefficient in a lot of developing countries.
Local governments need to set up effective systems for reviewing the ethical issues around the clinical trials which are authorized in different developing countries, and they need to do this by setting up ethical review committees that are independent of the government and research sponsors.
Although she may not know this, my encounter with Celine has completely changed the way in which I view HIV clinical trials in developing countries, and made me even more determined to be part of the movement to change the way in which things are done.
If you come from a developing country like myself, I urge you to hold your government to a more thorough review of the clinical trials which are authorized in your country.
We're still working at this story, we're still developing it, we're still expanding it.
I thought, why don't I make her an interactive Mother's Day card using the Scratch software that I'd been developing with my research group at the MIT Media Lab?
But working on this project enabled her to make a connection to someone that she cares about and enabled her to keep on learning new things and continuing to practice her creativity and developing new ways of expressing herself.
Combine that with a Demographic and Health Survey collected by USAID in developing countries in Africa, for example, which that survey actually can go so far as to directly measure the HIV status of families living in, for example, rural Nigeria.
A lot of people say now that business will lift up the developing economies, and social business will take care of the rest.
BackNext